Maternal Satisfaction After Spinal Anesthesia for Cesarean Delivery
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Bupivacaine %0.5 (hyperbaric), Bupivacaine %0.5 (hyperbaric) and morphine, Bupivacaine %0.5 (hyperbaric), morphine and fentanyl 15, Bupivacaine, morphine and fentanyl 20.
- Who it may be relevant to
- Registry conditions: Parturients, Elective Cesarean Delivery. Basic parameters: 18 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Maternal Satisfaction Following Different Spinal Anesthesia Regimens for Elective Cesarean Delivery: a Prospective Observational Study
Overview
The goal of this observational study is to evaluate the impact of four different spinal anesthesia regimens on maternal satisfaction following cesarean delivery. The main questions this study aims to answer are: * Primary outcome: Patient satisfaction with the provided analgesia during the first 24 hours postoperatively. * Secondary outcome: The need for rescue analgesics. Participants will complete a specially designed questionnaire 24 hours after cesarean delivery.
Interventions
- Drug Bupivacaine %0.5 (hyperbaric)
Only Bupivacaine %0.5 (hyperbaric) for spinal anesthesia - Drug Bupivacaine %0.5 (hyperbaric) and morphine
Combination of bupivacaine and morphine for spinal anesthesia - Drug Bupivacaine %0.5 (hyperbaric), morphine and fentanyl 15
Bupivacaine %0.5 (hyperbaric) , morphine and fentanyl 15 mcg for spinal anesthesia - Drug Bupivacaine, morphine and fentanyl 20
Bupivacaine, morphine and fentanyl 20 mcg for spinal anesthesia
Primary outcome measures
- Maternal satisfaction with provided analgesia during first 24 h following cesarean delivery [Time frame: 24 hours]
Secondary outcome measures (1)
- The need for rescue analgesics [Time frame: 24 hours]
Eligibility criteria
Inclusion Criteria: Parturients for elective cesarean delivery, ASA, status II and III, age between 18 and 45 years, singleton pregnancy, able to provide inform consent. -
Exclusion Criteria: Refuse to participate in the study, spinal anesthesia refused, known drug allergies to drugs included in the study, multiple pregnancy, preterm gestation, skin lesion at the beck, severe maternal comorbidities, chronic opioid use and chronic pain. -
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07438171 · 6-00-34/5